4//SEC Filing
Kulkarni Samarth 4
Accession 0001193125-25-240438
CIK 0001674416other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 5:35 PM ET
Size
9.5 KB
Accession
0001193125-25-240438
Insider Transaction Report
Form 4
Kulkarni Samarth
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Shares
2025-10-13+8,334→ 209,338 total - Exercise/Conversion
Restricted Stock Units
2025-10-13−8,334→ 8,333 total→ Common Shares (8,334 underlying) - Sale
Common Shares
2025-10-14$66.60/sh−4,242$282,517→ 205,096 total
Holdings
- 85,662(indirect: The Kulkarni 2023 GRAT)
Common Shares
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.
- [F3]This restricted stock unit award was granted on October 13, 2023 with respect to 25,000 Common Shares, with (i) one third of the shares vesting on October 13, 2024, (ii) one third of the shares vesting on October 13, 2025, and (iii) one third of the shares vesting on October 13, 2026.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001682019
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 5:35 PM ET
- Size
- 9.5 KB